Ryan E. Wilcox

Hematology

4403 Harrison Blvd Ste 2855
Ogden, UT 84403

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Regorafenib in Patients With Solid Tumors With BRAF Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Regorafenib in Patients With Solid Tumors With BRAF Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Journal: JCO precision oncology

Published: April 11, 2024

Showing 1-1 of 1

Last Updated: 09/26/2026